Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drug Development and Industrial Pharmacy is Scopus-indexed (Q2, CiteScore 3.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0363-9045Verify ISSN ↗1520-5762Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 88 / 191 | 54th | Q2 |
| Pharmacology | 194 / 328 | 40th | Q3 |
| Organic Chemistry | 130 / 215 | 39th | Q3 |
| Drug Discovery | 104 / 161 | 35th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1976–present (also 1974), best quartile Q2, CiteScore 3.6.
Drug Development and Industrial Pharmacy is Q2 in Pharmaceutical Science (rank 88 of 191), Q3 in Pharmacology (rank 194 of 328) and Q3 in Organic Chemistry (rank 130 of 215), by CiteScore 2025. It is ranked in 4 subject areas in all.
Drug Development and Industrial Pharmacy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.6, which places it in quartile Q2 at the 54th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.402, quartile Q2, with an H-index of 111.
Drug Development and Industrial Pharmacy is published by Taylor and Francis Ltd. Its print ISSN is 0363-9045 and its online ISSN is 1520-5762.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Drug Development and Industrial Pharmacy has an h-index of 126 and a 2-year mean of 2.57 citations per paper (OpenAlex). Its Scopus CiteScore is 3.6, quartile Q2. On 2-year citations it ranks #70 of 177 Scopus journals in Pharmaceutical Science.
Drug Development and Industrial Pharmacy published 167 papers in 2025; its busiest recent year was 2017 with 221. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2026), authors are most often from India (35.2%), China (10.9%) and Brazil (7.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 8 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.